严重继发性雷诺现象的多学科治疗：1例病例报告

doi:10.24920/004078

Chinese Medical Sciences Journal ›› 2022, Vol. 37 ›› Issue (4): 353-358.doi: 10.24920/004078

严重继发性雷诺现象的多学科治疗：1例病例报告

冷翠波¹,林冠军²,曹宏¹,刘子嘉^3,^*()

¹青岛大学附属青岛市中心医院青岛大学第二临床医学院麻醉科，青岛 266042
²青岛大学附属医院心血管外科，青岛 266000
³中国医学科学院北京协和医学院，北京协和医院麻醉科，北京 100730

收稿日期:2022-02-05 接受日期:2022-04-19 出版日期:2022-12-31 发布日期:2022-04-26
通讯作者: 刘子嘉 E-mail:liu-zj02@126.com

Multidisciplinary Treatment for Severe Secondary Raynaud’s Phenomenon: A Case Report

Cuibo Leng¹,Guanjun Lin²,Hong Cao¹,Zijia Liu^3,^*()

¹Department of Anesthesiology, Affiliated Qingdao Central Hospital of Qingdao University & Second Affiliated Hospital of Medical College of Qingdao University, Qingdao, Shandong 266042, China
²Department of Cardiovascular Surgery, Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, China
³Department of Anesthesiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Received:2022-02-05 Accepted:2022-04-19 Published:2022-12-31 Online:2022-04-26
Contact: Zijia Liu E-mail:liu-zj02@126.com

摘要/Abstract

摘要：

雷诺现象是指在寒冷或其他交感刺激因素的诱发下，出现间歇性指端缺血的特征性病变。继发性雷诺现象通常症状更为严重，甚至可导致指端溃疡，治疗也尤为复杂。我们报道了1例65岁女性因继发于亚临床甲状腺功能减退而出现严重的继发性雷诺现象，发作持续时间超过6小时。患者合并有甲状腺功能减退、癫痫、右中指及环指继发性软组织感染。经过多学科会诊与讨论，通过扩张血管、抗凝、甲状腺素替代、星状神经节阻滞、高压氧治疗及清创术等综合治疗，患者顺利康复，避免了截肢和明显的指端功能障碍。多学科诊疗模式(MDT)集合了各学科的专科力量，能为严重继发性雷诺现象患者提供最优治疗策略，可有效改善继发性雷诺现象患者的预后和满意度。

关键词: 继发性雷诺现象, 多学科, 星状神经节阻滞

Abstract:

Raynaud’s phenomenon is a symptom complex manifested as intermittent fingertip ischemia caused by cold or other sympathetic drivers. Secondary Raynaud’s phenomenon is often more severe and could even lead to finger ulceration, making it particularly complicated to treat. We describe a case of severe Raynaud’s phenomenon secondary to subclinical hypothyroidism lasting for more than 6 hours in a 65-year-old woman. The patient was also diagnosed with hypothyroidism, epilepsy, and secondary soft tissue infection of the right middle and ring fingers. After careful multidisciplinary consultation and discussion, the patient received vasodilation, anticoagulation, thyroxine supplementation, stellate ganglion block, hyperbaric oxygen therapy and debridement. The patient responded well to the medication, avoiding amputation or obviously dysfunction. Multidisciplinary team gathering the doctors from different departments proposes appropriate strategies for patients with severe Raynaud’s phenomenon and could improve the prognosis and satisfaction of patient effectively.

Key words: secondary Raynaud’s phenomenon, multidisciplinary, stellate ganglion block

Cuibo Leng, Guanjun Lin, Hong Cao, Zijia Liu. Multidisciplinary Treatment for Severe Secondary Raynaud’s Phenomenon: A Case Report[J].Chinese Medical Sciences Journal, 2022, 37(4): 353-358.

图/表 2

参考文献 20

[1]	Landry GJ. Current medical and surgical management of Raynaud’s syndrome. J Vasc Surg 2013; 57(6):1710-6. doi: 10.1016/j.jvs.2013.03.012. doi: 10.1016/j.jvs.2013.03.012
[2]	Gayraud M. Raynaud’s phenomenon. Joint Bone Spine 2007; 74(1):e1-8. doi: 10.1016/j.jbspin.2006.07.002. doi: 10.1016/j.jbspin.2006.07.002
[3]	Chikura B, Moore TL, Manning JB, et al. Sparing of the thumb in Raynaud’s phenomenon. Rheumatology (Oxford) 2008; 47(2):219-21. doi: 10.1093/rheumatology/kem353. doi: 10.1093/rheumatology/kem353 pmid: 18208825
[4]	Wigley FM, Flavahan NA. Raynaud’s Phenomenon. N Engl J Med 2016; 375(6):556-65. doi: 10.1056/NEJMra1507638. doi: 10.1056/NEJMra1507638
[5]	Pauling JD, Hughes M, Pope JE. Raynaud’s phenomenon—an update on diagnosis, classification and management. Clin Rheumatol 2019; 38(12):3317-30. doi: 10.1007/s10067-019-04745-5. doi: 10.1007/s10067-019-04745-5 pmid: 31420815
[6]	Belch J, Carlizza A, Carpentier PH, et al. ESVM guidelines— the diagnosis and management of Raynaud’s phenomenon. Vasa 2017; 46(6):413-23. doi: 10.1024/0301-1526/a000661. doi: 10.1024/0301-1526/a000661 pmid: 28895508
[7]	Juche A, Siegert E, Mueller-Ladner U, et al. Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany. Z Rheumatol 2020; 79(10):1057-66. doi: 10.1007/s00393-019-00743-9. doi: 10.1007/s00393-019-00743-9
[8]	Hughes M, Ong VH, Anderson ME, et al. Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis. Rheumatology (Oxford) 2015; 54(11):2015-24. doi: 10.1093/rheumatology/kev201. doi: 10.1093/rheumatology/kev201 pmid: 26116156
[9]	Rinkinen J, Halvorson EG. Topical vasodilators in microsurgery: what is the evidence? J Reconstr Microsurg 2017; 33(1):1-7. doi: 10.1055/s-0036-1592191. doi: 10.1055/s-0036-1592191 pmid: 27636540
[10]	Ma Q, Liu D, Gong R, et al. Mechanically induced vasospasm-evaluation of spasmolytic efficacy of 10 pharmaceutical agents using laser speckle contrast imaging. Lasers Surg Med 2021; 53(5):684-94. doi: 10.1002/lsm.23347. doi: 10.1002/lsm.23347 pmid: 33259664
[11]	Vargas CR, Iorio ML, Lee BT. A systematic review of topical vasodilators for the treatment of intraoperative vasospasm in reconstructive microsurgery. Plast Reconstr Surg 2015; 136(2):411-22. doi: 10.1097/PRS.0000000000001431. doi: 10.1097/PRS.0000000000001431 pmid: 25909299
[12]	Andrigueti FV, Ebbing PCC, Arismendi MI, et al. Evaluation of the effect of sildenafil on the microvascular blood flow in patients with systemic sclerosis: a randomised, double-blind, placebo-controlled study. Clin Exp Rheumatol 2017; 106(4):151-8.
[13]	Hachulla E, Hatron PY, Carpentier P, et al. Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study. Ann Rheum Dis 2016; 75(6):1009-15. doi: 10.1136/annrheumdis-2014-207001. doi: 10.1136/annrheumdis-2014-207001 pmid: 25995322
[14]	Sahin OF, Tarikci Kilic E, Aksoy Y, et al. The importance of perfusion index monitoring in evaluating the efficacy of stellate ganglion blockage treatment in Raynaud’s disease. Libyan J Med 2018; 13(1): 1422666. doi: 10.1080/19932820.2017.1422666. doi: 10.1080/19932820.2017.1422666
[15]	Vegas DH, Fabiani MA, Gonzalez-Urquijo M, et al. Novel combined approach for digital necrosis secondary to Raynaud’s phenomenon. Vasc Endovascular Surg 2021; 55(7):766-71. doi: 10.1177/15385744211005663. doi: 10.1177/15385744211005663
[16]	Isei T, Abe M, Nakanishi T, et al. The wound/burn guidelines-3: guidelines for the diagnosis and treatment for diabetic ulcer/gangrene. J Dermatol 2016; 43(6):591-619. doi: 10.1111/1346-8138.13285. doi: 10.1111/1346-8138.13285
[17]	Thom SR. Hyperbaric oxygen: its mechanisms and efficacy. Plast Reconstr Surg 2011; 127(Suppl 1):131S-41S. doi: 10.1097/PRS.0b013e3181fbe2bf. doi: 10.1097/PRS.0b013e3181fbe2bf
[18]	Howard MA, Asmis R, Evans KK, et al. Oxygen and wound care: a review of current therapeutic modalities and future direction. Wound Repair Regen 2013; 21(4):503-11. doi: 10.1111/wrr.12069. doi: 10.1111/wrr.12069 pmid: 23756299
[19]	Sato T, Arai K, Ichioka S. Hyperbaric oxygen therapy for digital ulcers due to Raynaud’s disease. Case Reports Plast Surg Hand Surg 2018; 5(1):72-4. doi: 10.1080/23320885.2018.1525684. doi: 10.1080/23320885.2018.1525684
[20]	Herrick A, Muir L. Raynaud’s phenomenon (secondary). BMJ Clin Evid 2014; 2014:1125.

优先出版

当期目次

过刊浏览

虚拟专题

作者中心

评阅者中心

严重继发性雷诺现象的多学科治疗：1例病例报告

Multidisciplinary Treatment for Severe Secondary Raynaud’s Phenomenon: A Case Report

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 2

参考文献 20

相关文章 0

Metrics

推荐阅读 10